112 related articles for article (PubMed ID: 15090600)
1. Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton.
Harrison RE; Sikorski BA; Jongstra J
J Cell Sci; 2004 Apr; 117(Pt 10):2151-7. PubMed ID: 15090600
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of anti-IgM-induced translocation of protein kinase C beta I inhibits ERK2 activation and increases apoptosis.
Cao MY; Shinjo F; Heinrichs S; Soh JW; Jongstra-Bilen J; Jongstra J
J Biol Chem; 2001 Jul; 276(27):24506-10. PubMed ID: 11333276
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
[TBL] [Abstract][Full Text] [Related]
4. The actin-binding protein, lymphocyte-specific protein 1, is expressed in human leukocytes and human myeloid and lymphoid cell lines.
Li Y; Guerrero A; Howard TH
J Immunol; 1995 Oct; 155(7):3563-9. PubMed ID: 7561054
[TBL] [Abstract][Full Text] [Related]
5. C3G mediated suppression of malignant transformation involves activation of PP2A phosphatases at the subcortical actin cytoskeleton.
MartÃn-Encabo S; Santos E; Guerrero C
Exp Cell Res; 2007 Nov; 313(18):3881-91. PubMed ID: 17825818
[TBL] [Abstract][Full Text] [Related]
6. Plasma membrane Ca(2+) -ATPase associates with CLP36, alpha-actinin and actin in human platelets.
Bozulic LD; Malik MT; Powell DW; Nanez A; Link AJ; Ramos KS; Dean WL
Thromb Haemost; 2007 Apr; 97(4):587-97. PubMed ID: 17393022
[TBL] [Abstract][Full Text] [Related]
7. The lymphocyte-specific protein LSP1 is associated with the cytoskeleton and co-caps with membrane IgM.
Klein DP; Galea S; Jongstra J
J Immunol; 1990 Nov; 145(9):2967-73. PubMed ID: 2212669
[TBL] [Abstract][Full Text] [Related]
8. SNT-2 interacts with ERK2 and negatively regulates ERK2 signaling in response to EGF stimulation.
Huang L; Gotoh N; Zhang S; Shibuya M; Yamamoto T; Tsuchida N
Biochem Biophys Res Commun; 2004 Nov; 324(3):1011-7. PubMed ID: 15485655
[TBL] [Abstract][Full Text] [Related]
9. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
10. MEK/ERK regulates adherens junctions and migration through Rac1.
Ray RM; Vaidya RJ; Johnson LR
Cell Motil Cytoskeleton; 2007 Mar; 64(3):143-56. PubMed ID: 17183546
[TBL] [Abstract][Full Text] [Related]
11. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
12. JWA as a functional molecule to regulate cancer cells migration via MAPK cascades and F-actin cytoskeleton.
Chen H; Bai J; Ye J; Liu Z; Chen R; Mao W; Li A; Zhou J
Cell Signal; 2007 Jun; 19(6):1315-27. PubMed ID: 17336041
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
[TBL] [Abstract][Full Text] [Related]
14. Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation.
Lee JH; Katakai T; Hara T; Gonda H; Sugai M; Shimizu A
J Cell Biol; 2004 Oct; 167(2):327-37. PubMed ID: 15504914
[TBL] [Abstract][Full Text] [Related]
15. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
[TBL] [Abstract][Full Text] [Related]
16. Expression of kinase suppressor of Ras1 enhances cisplatin-induced extracellular signal-regulated kinase activation and cisplatin sensitivity.
Kim M; Yan Y; Kortum RL; Stoeger SM; Sgagias MK; Lee K; Lewis RE; Cowan KH
Cancer Res; 2005 May; 65(10):3986-92. PubMed ID: 15899786
[TBL] [Abstract][Full Text] [Related]
17. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
18. RbAp48 regulates cytoskeletal organization and morphology by increasing K-Ras activity and signaling through mitogen-activated protein kinase.
Scuto A; Zhang H; Zhao H; Rivera M; Yeatman TJ; Jove R; Torres-Roca JF
Cancer Res; 2007 Nov; 67(21):10317-24. PubMed ID: 17974974
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte-specific gene 1 protein (LSP1) is involved in chemokine KC-activated cytoskeletal reorganization in murine neutrophils in vitro.
Hannigan M; Zhan L; Ai Y; Huang CK
J Leukoc Biol; 2001 Mar; 69(3):497-504. PubMed ID: 11261799
[TBL] [Abstract][Full Text] [Related]
20. Human diploid fibroblasts are resistant to MEK/ERK-mediated disruption of the actin cytoskeleton and invasiveness stimulated by Ras.
Sukezane T; Oneyama C; Kakumoto K; Shibutani K; Hanafusa H; Akagi T
Oncogene; 2005 Aug; 24(36):5648-55. PubMed ID: 16007212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
